You are currently browsing the Gene therapy category
§ May 6th, 2012 § Filed under Gene therapy Comments Off
Authors: B Thaci, A U Ahmed, I V Ulasov, A L Tobias, Y Han, K S Aboody & M S Lesniak (Source: Cancer Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
Read the Rest...
§ May 6th, 2012 § Filed under Gene therapy Comments Off
Interferon-β lipofection II. Mechanisms involved in cell death and bystander effect induced by cationic lipid-mediated interferon-β gene transfer to human tumor cells Cancer Gene Therapy advance online publication, May 4, 2012. doi:10.1038/cgt.2012.19 Authors: M S Villaverde, M L Gil-Cardeza, G C Glikin & L M E Finocchiaro (Source: Cancer Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
Read the Rest...
§ May 6th, 2012 § Filed under Gene therapy Comments Off
Authors: P B Card, R T Hogg, C R Gil del Alcazar & R D Gerard (Source: Cancer Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
Read the Rest...
§ May 6th, 2012 § Filed under Gene therapy Comments Off
Authors: Y Tian, B Guo, H Jia, K Ji, Y Sun, Y Li, T Zhao, L Gao, Y Meng, D V Kalvakolanu, D J Kopecko, X Zhao, L Zhang & D Xu (Source: Cancer Gene Therapy) MedWorm Sponsor Message: Please support the Doctors In Chains campaign for the medics tortured and sentenced for up to [...]
Read the Rest...
§ May 6th, 2012 § Filed under Gene therapy Comments Off
By Ewen Callaway of Nature magazine [More] Source:http://rss.sciam.com/sciam/topic/gene-therapy
Read the Rest...
§ May 6th, 2012 § Filed under Gene therapy Comments Off
Adoptive cell therapy with tumor-targeted T cells is a promising approach to cancer therapy. Enhanced clinical outcome using this approach requires conditioning regimens with total body irradiation, lymphodepleting chemotherapy, and/or additional cytokine support. However, the need for prior conditioning precludes optimal application of this approach to a significant number of cancer patients intolerant to these [...]
Read the Rest...
§ May 6th, 2012 § Filed under Gene therapy Comments Off
Authors: I M Barbash, S Cecchini, A Z Faranesh, T Virag, L Li, Y Yang, R F Hoyt, J N Kornegay, J R Bogan, L Garcia, R J Lederman & R M Kotin (Source: Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
Read the Rest...
§ May 6th, 2012 § Filed under Gene therapy Comments Off
Authors: J C M van der Loo, W P Swaney, E Grassman, A Terwilliger, T Higashimoto, A Schambach, S Hacein-Bey-Abina, D L Nordling, M Cavazzana-Calvoo, A J Thrasher, D A Williams, L Reeves & P Malik (Source: Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
Read the Rest...
§ May 6th, 2012 § Filed under Gene therapy Comments Off
The Advances news section in April's issue of Scientific American included stories on digital textbooks, the promise of using gene therapy to fight blindness and how fragile orchids survive. To learn more about any of the stories, follow these links. [More] Source:http://rss.sciam.com/sciam/topic/gene-therapy
Read the Rest...
§ April 29th, 2012 § Filed under Gene therapy Comments Off
Research and Markets has announced the addition of GlobalData's new report "Breaking the Gene Therapy BarrierSource:http://news.search.yahoo.com/news/rss?ei=UTF-8&p=gene+therapy&eo=UTF-8
Read the Rest...
§ April 29th, 2012 § Filed under Gene therapy Comments Off
In conclusion, adoptive immunotherapy with CD20-specific T cells was well tolerated and was associated with antitumor activity. We will pursue alternative gene transfer technologies and culture conditions in future studies to improve CAR expression and cell production efficiency. This study is registered at www.clinicaltrials.gov as NCT00621452. (Source: Blood) MedWorm Sponsor Message: Please have a look [...]
Read the Rest...
§ April 29th, 2012 § Filed under Gene therapy Comments Off
Authors: T Tang, M H Gao & H Kirk Hammond (Source: Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
Read the Rest...
§ April 29th, 2012 § Filed under Gene therapy Comments Off
Gene Therapy advance online publication, April 26, 2012. doi:10.1038/gt.2012.35 Author: J K Donahue (Source: Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
Read the Rest...
§ April 29th, 2012 § Filed under Gene therapy Comments Off
Authors: S P Grekova, Z Raykov, R Zawatzky, J Rommelaere & U Koch (Source: Cancer Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
Read the Rest...
§ April 29th, 2012 § Filed under Gene therapy Comments Off
Authors: Y Yang, X-m Zhang, N Zhang, L Cheng, C Li, S Zhang, J-f Zhang, L Dai, H-w Tian, N Yan, P Fan, L-x Dai, F Xu, G Shi, X-l Chen, T Du, Y-m Li, Y-Q Wei & H-X Deng (Source: Cancer Gene Therapy)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
Read the Rest...
§ April 29th, 2012 § Filed under Gene therapy Comments Off
Authors: Turrell SJ, Macnab SA, Rose A, Melcher AA, Whitehouse A Abstract Herpesvirus saimiri (HVS) is capable of infecting a range of human carcinoma cell types with high efficiency and the viral genome persists as high copy number, circular, non-integrated episomes which segregate to progeny upon cell division. This allows HVS-based vectors to stably transduce [...]
Read the Rest...
§ April 29th, 2012 § Filed under Gene therapy Comments Off
In this study, CaCO(3) delivering pEGFP-C1-p53 could transfect about 5% of the tumor cells in culture. However, the efficiency of tumor cell apoptosis was surprisingly up to 80%. Meanwhile, the results of MTT assay and crystal violet staining showed that the CaCO(3) microparticles had low cytotoxicity. These findings showed that CaCO(3) microparticles were perspective to [...]
Read the Rest...
§ April 29th, 2012 § Filed under Gene therapy Comments Off
Molecular imaging is revolutionizing the way we study the inner workings of the human body, diagnose diseases, approach drug design, and assess therapies. The field as a whole is making possible the visualization of complex biochemical processes involved in normal physiology and disease states, in real time, in living cells, tissues, and intact subjects. In [...]
Read the Rest...
§ April 29th, 2012 § Filed under Gene therapy Comments Off
Conclusion: These data suggest that rAAV-mediated soluble TRAIL expression under the control of the Tet-On system is a promising strategy for breast cancer therapy. (Source: BMC Cancer)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
Read the Rest...
§ April 29th, 2012 § Filed under Gene therapy Comments Off
ConclusionThese results suggest that epirubicin enhances the antiarthritic effect of rAAV2/5?TRAIL and that combination treatment might be an important therapeutic alternative, with practical significance for rheumatoid arthritis. (Source: Arthritis and Rheumatism)Source:http://www.medworm.com/rss/medicalfeeds/therapies/Gene-Therapy.xml
Read the Rest...
« Older Entries
Newer Entries »